No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. Read more about No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.
The current state of preclinical prostate cancer animal models. Read more about The current state of preclinical prostate cancer animal models.
High resolution oligonucleotide CGH using DNA from archived prostate tissue. Read more about High resolution oligonucleotide CGH using DNA from archived prostate tissue.
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. Read more about Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. Read more about Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.
Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Read more about Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Ethnic and racial differences in prostate stromal estrogen receptor alpha. Read more about Ethnic and racial differences in prostate stromal estrogen receptor alpha.
Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Read more about Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Molecular targets of doxazosin in human prostatic stromal cells. Read more about Molecular targets of doxazosin in human prostatic stromal cells.
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Read more about Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
